A Evaluation the effect of ginseng plant root extract on complications of Azathioprine on ovarian follicles and TSH, LH and Progesterone hormones in rats
Main Article Content
Abstract
Background: The search for herbal remedies has gained significant attention due to the potential harmful side effects associated with chemical drugs. Finding plants that can mitigate these adverse effects is crucial for enhancing the well-being of individuals undergoing chemical drug treatments.
Aim: Numerous studies have demonstrated the potent antioxidant properties of ginseng. Azathioprine, a widely used drug, has been shown to induce detrimental side effects on various body tissues. Thus, this study aimed to assess the efficacy of ginseng in reducing the harmful effects of azathioprine on ovarian tissue.
Materials and Methods: In this study, mice were divided into different groups and injected with ginseng root extract along with azathioprine. Ovarian weight and histological analysis were conducted to evaluate the number of ovarian follicles and corpus luteum. Furthermore, the levels of FSH, LH, and progesterone in the blood of the study groups were assessed using ELISA.
Results: In treatment group 4 (ginseng extract and azathioprine), compared to treatment group 2 (azathioprine only), a significant increase in the weight of both left and right ovaries was observed. Treatment group 4 also exhibited a notable increase (P<0.05) in the number of primordial, primary, and atretic follicles. The concentration of progesterone significantly increased in treatment group 4 compared to treatment group 2 (P<0.01).
Conclusion: The findings of this study indicate that azathioprine can have destructive effects on ovarian tissues, while ginseng extract demonstrates potential in reducing these detrimental side effects. Furthermore, ginseng extract appears to positively regulate FSH and progesterone hormones.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
2. Kim J-H. Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases. J Ginseng Res 2018;42(3):264–9.
3. Arriving NM, Millstone D, Marks LA, Nail LM. Ginseng as a treatment for fatigue: a systematic review. J Altern Complement Med 2018;24(7):624–33.
4. Chen F, Huang G. Antioxidant activity of polysaccharides from different sources of ginseng. Int J Biol Macromol 2019;125:906–8.
5. Karmazyn M, Gan XT. Chemical components of ginseng, their biotransformation products and their potential to treat hypertension. Mol Cell Biochem 2021;476(1):333–47.
6. Shi Z-Y, Zeng J-Z, Wong AST. Chemical structures and pharmacological profiles of ginseng saponins. Molecules 2019;24(13):2443.
7. Ekladious A, Mohamad A. Prescribing Azathioprine in Medicine and Surgery. J Surg Res 2021;4(2):284–6.
8. Dean L. Azathioprine therapy and TPMT and NUDT15 genotype. Med Genet Summ [Internet] 2020;
9. Van Zyl J, Wissmüller HF. The clastogenic effect of azathioprine on human chromosomes in vitro. Humangenetik 1974;21(2):153–65.
10. Maltzman JS, Koretzky GA. Azathioprine: old drug, new actions. J Clin Invest 2003;111(8):1122–4.
11. Mohammadi O, Kassim TA. Azathioprine. 2019;
12. Barshes NR, Goodpastor SE, Goss JA. Pharmacologic immunosuppression. Front Biosci 2004;9:411–20.
13. Millard TP, Hawk JLM. Photosensitivity disorders. Am J Clin Dermatol 2002;3(4):239–46.
14. Mishra K, Pramanik S, Sandal R, Jandial A, Sahu KK, Singh K, et al. Safety and efficacy of azathioprine in immune thrombocytopenia. Am J Blood Res 2021;11(3):217.
15. Do J-H, Lee H-O, Lee S-K, Jang J-K, Lee S-D, Sung H-S. Panax ginseng, its Extraction Condition and Stability. Korean J Ginseng Sci 1993;17(2):139–44.
16. Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. Jama 2018;320(13):1360–72.
17. Suarez‐Almazor ME, Spooner C, Belseck E. Azathioprine for treating rheumatoid arthritis. Cochrane Database Syst Rev 2000;(4).
18. Sands K, Jansen R, Zaslau S, Greenwald D. the safety of therapeutic drugs in male inflammatory bowel disease patients wishing to conceive. Aliment Pharmacol Ther 2015;41(9):821–34.
19. Park S-W, Lee S-M. Antioxidant and prooxidant properties of ascorbic acid on hepatic dysfunction induced by cold ischemia/reperfusion. Eur J Pharmacol 2008;580(3):401–6.
20. Okan G, Vural P, Peker O, Colakoglu E, Saruc M. Azathioprine-induced liver injury in a patient with multiple autoimmune syndrome. J Dermatolog Treat 2010;21(6):357–60.
21. Rizzo A, Roscino MT, Binetti F, Sciorsci RL. Roles of reactive oxygen species in female reproduction. Reprod Domest Anim 2012;47(2):344–52.
22. Luderer U. Ovarian toxicity from reactive oxygen species. Vitam Horm 2014;94:99–127.
23. Mattison DR, Chang L, Thorgeirsson SS, Shimizu K. The effects of cyclophosphamide, azathioprine, and 6-mercaptopurine on oocyte and follicle number in C57BL/6N mice. Res Commun Chem Pathol Pharmacol 1981;31(1):155–61.
24. Kang J-K, Lee Y-J, No K-O, Jung E-Y, Sung J-H, Kim Y-B, et al. Ginseng intestinal metabolite-I (GIM-I) reduces doxorubicin toxicity in the mouse testis. Reprod Toxicol 2002;16(3):291–8.
25. Kamel MEF, Mohammad HMF, Maurice C, Hagras MM. Ginseng Nanoparticles Protect Against Methotrexate-Induced Testicular Toxicity in Rats. Egypt J Basic Clin Pharmacol 2019;9.
26. Kim JY, Lee HJ, Kim JS, Ryu J-H. Induction of nitric oxide synthase by saponins of heat-processed ginseng. Biosci Biotechnol Biochem 2005;69(5):891–5.
27. del Mar Montesinos M, Nicola JP, Nazar M, Peyret V, Lucero AM, Pellizas CG, et al. Nitric oxide-repressed Forkhead factor FoxE1 expression is involved in the inhibition of TSH-induced thyroid peroxidase levels. Mol Cell Endocrinol 2016;420:105–15.
28. Taneja V. Sex hormones determine immune response. Front Immunol 2018;9:1931.